Rubicon Research's Q3 FY 2025-26 Quarterly Results
- 04 Feb 2026
Result Summary
- Rubicon Research Ltd reported a 16.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.
- Its expenses for the quarter were up by 14.0% QoQ and - - YoY.
- The net profit increased 35.2% QoQ and - - YoY.
- The earnings per share (EPS) of Rubicon Research Ltd stood at 4.41 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 479.32 | 412.72 | 0.00 | 16.1% | - |
Total Expenses | 388.72 | 341.01 | 0.00 | 14.0% | - |
Profit Before Tax | 90.59 | 71.70 | - | 26.3% | NaN% |
Tax | 17.79 | 17.85 | 0.00 | -0.3% | - |
Profit After Tax | 72.80 | 53.85 | 0.00 | 35.2% | - |
Earnings Per Share | 4.41 | 3.47 | 0.00 | 27.1% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Rubicon Research Ltd is a company involved in the pharmaceutical industry, primarily focused on research and development. The company specializes in developing complex generics and value-added formulations. Rubicon Research Ltd is known for its innovative solutions in drug delivery technologies, which cater to unmet needs in the pharmaceutical sector. While the specific details of recent major developments are not available from the provided information, the company's continued focus on R&D and formulation development is a key part of its business strategy.
Revenue
In the third quarter of fiscal year 2026 (Q3FY26), Rubicon Research Ltd reported a total income of ₹479.32 crores. This represents a quarter-over-quarter (QoQ) increase of 16.1% from ₹412.72 crores in the second quarter of fiscal year 2026 (Q2FY26). There is no year-over-year (YoY) comparison available for Q3FY25 as the data is marked as 0.00. The company's increase in total income over the quarter signifies growth within the reporting period, which may be attributed to various factors such as increased sales or expansion in market reach, although specific reasons are not detailed in the provided data.
Profitability
Rubicon Research Ltd's profitability metrics indicate a strong performance in Q3FY26. The profit before tax (PBT) for the period stands at ₹90.59 crores, which is a 26.3% increase from the previous quarter (Q2FY26), where the PBT was ₹71.70 crores. The profit after tax (PAT) in Q3FY26 is ₹72.80 crores, marking a 35.2% increase from the PAT of ₹53.85 crores in Q2FY26. The tax expense for Q3FY26 was ₹17.79 crores, slightly down by 0.3% from ₹17.85 crores in Q2FY26. Earnings per share (EPS) rose to ₹4.41 from ₹3.47, reflecting a 27.1% increase over the quarter. These figures demonstrate an improvement in the company's profitability from the previous quarter.
Operating Metrics
The total expenses for Rubicon Research Ltd in Q3FY26 were ₹388.72 crores, which shows a 14.0% increase from ₹341.01 crores in Q2FY26. The increase in expenses coincides with the rise in total income, suggesting operational scaling during the quarter. The company’s focus on managing its expenses relative to its income is evident in the financial data provided. Key financial ratios such as P/E ratio, debt-to-equity ratio, and current ratio are not calculable from the given data, as specific values required for these calculations, such as market price per share or total liabilities, are not available. The trends in total expenses and income suggest a period of growth, although the specific drivers of these changes are not explained in the data available.